GAMBARAN KADAR SGOT,SGPT DAN BILIRUBIN PADA PASIEN KOLELITIASI DI RSI SITI RAHMAH PADA TAHUN 20121-2023

Authors

  • Mhd Nurhuda Universitas Baiturrahmah
  • Yusti Siana Universitas Baiturrahmah
  • Mutiara Annisa Universitas Baiturrahmah

DOI:

https://doi.org/10.59003/nhj.v3i8.1097

Keywords:

Cholelithiasis, SGOT, SGPT, Total Bilirubin

Abstract

Cholelithiasis or gallstones form from an imbalance of chemical content in bile that causes the deposition of one or more of the bile components. According to data from the World Health Organization (WHO), the incidence of cholelithiasis in the world was 11.7% in 2017. Risk factors are closely related to cholelithiasis such as age, sex, and BMI. Usually, gallstones that block the bile ducts can cause damage to liver cells and inhibit bile flow which can affect liver function such as SGOT, SGPT, and bilirubin which will indicate liver damage. Objective: Knowing how the description of SGOT, SGPT, and bilirubin levels in cholelithiasis patients at RSI Siti Rahmah Padang in 2021-2023. Method: This type of research is a categorical descriptive study with a cross- sectional study approach design, with the estimated population in this study being patients with cholelithiasis at RSI Siti Rahmah Padang in 2021-2023 with 86 samples using purposive sampling techniques. Univariate data analysis is presented in the form of frequency. Results: From a total sample of 86 people, most of the cholelithiasis sufferers at the age of ≥ 51 years were 41 people (47.7%), most were female at 58 people (67.4%), most with normal BMI at 55 people, most with normal SGOT levels at 62 people (72.1%), most with normal SGOT levels at 53 people (61.6), Most with normal total bilirubin levels of 56 people (65.1%), most with elevated total bilirubin levels of 48 people (55.8%), most with normal indirect levels of 60 people (69.8%). Conclusion: Most patients with ≥ age 51 years, most patients are female, most patients with normal levels of SGOT, SGPT, total bilirubin and indirect bilirubin and most patients with elevated bilirubin levels.

Downloads

Download data is not yet available.

References

. Ndraha S, Febriani H, Tan T H, Tendean M. Profil Kolelitiasis pada Hasil Ultrasonografi di Rumah Sakit Umum Daerah Koja. J Kedokt Meditek. 2018;24(68):7–11.

. Febyan F, Singh Dhilion HR, Ndraha S, Tendean M. Karakteristik Penderita Kolelitiasis Berdasarkan Faktor Risiko di Rumah Sakit Umum Daerah Koja. Jurnal Kedokteran Meditek. 2017;23(63):50–6.

. Lesmana L. Penyakit Batu Empedu. 4th ed. jakarta: Penerbit Departemen Ilmu Penyakit Dalam Fakultas Krdokteran Universitas Indonesia; 2006.

. Tuuk ALZ, Panelewen J, Noersasongko AD. Profil kasus batu empedu di RSUP Prof . Dr . R . D . Kandou Manado Jimmy Panelewen. Jurnal e-Clinic. 2016;4(2):2–7.

. Fakultas M, Universitas K, Histologi B, Kedokteran F, Farmakologi B, Kedokteran F, et al. Hubungan Peningkatan Indeks Massa Tubuh dengan Kejadian Kolelitiasis di Bagian Bedah Digestif RSI Siti Rahmah Padang Periode Januari - Juni 2018. 2018;

. Littlefield A, Lenahan C. Cholelithiasis: Presentation and Management. J Midwifery Womens Health.

;64(3):289–97.

. Essentials P. Gallstones ( Cholelithiasis ). 2019;1–25.

. tanaja j, Lopez RA MJ. Cholelithiasis. Treasure Island : StatPearls. 2022.

. Aji SP, Arania R, Maharyunu E. Hubungan Usia, Jenis Kelamin, Dan Kadar Bilirubin Dengan Kolelitiasis. Jurnal Wacana Kesehatan. 2021;5(2):583.

. Insang GK, Kaur P. Evaluasi Parameter Hati Dan Lipid Pada Kolelitiasis. 2019;12.

. Aleya, Berawi KN. Korelasi Pemeriksaan Laboratorium SGOT/SGPT dengan Kadar Bilirubin pada Pasien Hepatitis C. Majority Journal. 2014;4(9):135–9.

. Pak M, Lindseth G. Risk factors for cholelithiasis. Gastroenterology Nursing. 2016;39(4):297–309. [13]. Reshetnyak V. No TitleConcept of the pathogenesis and treatment of cholelithiasis. World J Hepatol;

18–34 p.

. Gill GK, Kaur P. Evaluation Of Liver And Lipid Parameters In Cholelithiasis. Asian Journal of Pharmaceutical and Clinical Research. 2019 Jul 4;64–7.

. Aji SP, Arania R, Maharyuni E. Hubungan Usia, Jenis Kelamin, Dan Kadar Bilirubindengan Kolelitiasis.

Vol. 5, Jurnal Wacana Kesehatan. 2020.

. Alaasswad N, Ekrim K, Al-Aasswad NM, Alsayah AA, Eshnaf IA. Gallstones And Liver Function. Vol.

, European Journal Pharmaceutical and Medical Research. 2022.

. Kee J. Pedoman Pemeriksaan Laboratorium & Diagnostik. 6 th edn. Jakarta : Buku Kedokteran EGC; 2014.

. Tanaja J, Lopez RA, Meer JM. Cholelithiasis. 2023.

. Tripathi N, Jialal I. Conjugated Hyperbilirubinemia. 2023. [20]. Hoilat GJ, John S. Bilirubin. StatPearls. 2023;

. Landazury, Nella; Gallardo, Jacqueline; Sanchez N. Obesity and Gallstones. Visceral Medicine. 2021 [22]. Miner E. Direct Bilirubin. In: Health Encyclopedia.

. Lodha M, Chauhan AS, Puranik A, Meena SP, Badkur M, Chaundhary R, dkk. Clinical Profile and Evaluation of Outcomes of Sympomatic Gallstone Disease in the Senior Citizen Population. Cureus. 2022

Downloads

Published

2024-01-10

How to Cite

Nurhuda, M., Siana, Y., & Annisa, M. (2024). GAMBARAN KADAR SGOT,SGPT DAN BILIRUBIN PADA PASIEN KOLELITIASI DI RSI SITI RAHMAH PADA TAHUN 20121-2023. Nusantara Hasana Journal, 3(8), 306–317. https://doi.org/10.59003/nhj.v3i8.1097

Most read articles by the same author(s)